Ignite Creation Date:
2025-12-24 @ 4:05 PM
Ignite Modification Date:
2026-02-07 @ 10:20 PM
Study NCT ID:
NCT03197766
Status:
COMPLETED
Last Update Posted:
2022-03-02
First Post:
2017-05-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia
Sponsor:
BioMarin Pharmaceutical
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Achondroplasia | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Achondroplasia | View |
| None | Dwarfism | View |
| None | Bone Diseases | View |
| None | Bone Diseases, Developmental | View |
| None | ACH | View |
| None | Natriuretic Peptide, C-Type | View |
| None | Musculoskeletal Diseases | View |
| None | Natriuretic Agents | View |
| None | Physiological Effects of Drugs | View |
| None | Skeletal Dysplasias | View |
| None | Genetic Diseases, Inborn | View |
| None | Osteochondrodysplasias | View |